ARTELO BIOSCIENCES, INC. Debt Securities, Available-for-sale, Current
ARTELO BIOSCIENCES, INC. (ARTL) had Debt Securities, Available-for-sale, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2024-03-25
- 2023-12-31: Debt Securities, Available-for-sale, Current $0.00.
- 2023-09-30: Debt Securities, Available-for-sale, Current $0.00.
- 2023-06-30: Debt Securities, Available-for-sale, Current $0.00.
- 2023-03-31: Debt Securities, Available-for-sale, Current $0.00.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.50M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.49M 10-Q · filed 2022-11-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-08-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |